Neurodegenerative disease Archives

In Depth 9 Dec 2019

As Big Pharma Abandons Neuroscience, Can Biotech Provide Answers?

With big pharma exiting the neurology space in droves, biotech innovation might be the key to bring about a much-needed shift. At the Bio-Europe conference in Hamburg last month, experts weighed in on the challenges and future of neuroscience. Over the last decade, big pharma has become disillusioned with neuroscience research. Eli Lilly, Amgen, Pfizer, […]

December 9, 2019 - 9 minutesmins - By Clara Rodríguez Fernández

More News! 27 Jun 2019

German Biotech Will Target Parkinsonian Disorders with €12M Series A

Modag has developed a candidate drug targeting the neurodegenerative disease multiple system atrophy, which it plans to take to the clinic with €12M in Series A funds. Multiple system atrophy is a rare disorder, with similar symptoms to Parkinson’s disease, that is caused by breakdown of neurons in parts of the brain. The German biotech’s […]

June 27, 2019 - 2 minutesmins - By Helen Albert

Best in Biotech 8 May 2019

Top 10 Biotechs in Lausanne

The Swiss city of Lausanne is perhaps best known as a hub of international sport, but what many outsiders may not realize is that it’s also one of Switzerland’s biggest biotech hubs. Many of the biotechs in the city are connected to the University of Lausanne (UNIL), as well as the renowned Swiss Federal Institute […]

May 8, 2019 - 7 minutesmins - By David Cox

bioarctic alzheimers disease plaques amyloid beta neurons Edited

More News! 25 Mar 2019

Swedish Biotech’s Stock Severely Hit by Failure of Biogen’s Alzheimer’s Drug

The failure of Biogen’s Alzheimer’s disease drug in a phase III trial last week caused BioArctic’s stock price to plummet by 35% on Nasdaq Stockholm. The Swedish company has just begun a phase III trial of its own Alzheimer’s treatment. Last week, Biogen and its pharma collaborator Eisai discontinued the phase III development of an […]

March 25, 2019 - 2 minutesmins - By Jonathan Smith

huntingtons disease gene therapy uniqure2 1

News and Trends 23 Jan 2019

Update: The FDA Green-lights Clinical Trials for Huntington’s Disease Gene Therapy

Update (23/01/2019): The FDA has given uniQure regulatory clearance to begin a phase I/II trial of its gene therapy for Huntington’s disease. uniQure is planning to launch the trial in the US in late 2019. Published on 23/01/2018: The EMA has given uniQure’s gene therapy candidate for Huntington’s disease Orphan Medicinal Product Designation, which the […]

January 23, 2019 - 3 minutesmins - By Alex Dale

NMD pharma aarhus denmark neuromuscular disorder 1

Startup Scout 14 Dec 2018

This Company is Strengthening Muscles in Neuromuscular Disorders

NMD Pharma, our pick of this week, is based in Aarhus, Denmark. The company is flexing its muscles to develop a drug that can treat muscle weakness in orphan neuromuscular disorders such as amyotrophic lateral sclerosis and myasthenia gravis. Mission: To develop drugs to counteract muscle weakness in incurable neuromuscular disorders. Neuromuscular disorders come […]

December 14, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 9 Aug 2018

Modulating the Microbiome Could Boost Vaccine Performance

Dutch scientists have found that altering a patient’s microbiome with antibiotics before a vaccination can boost the body’s resulting immune response against rotavirus infection. Rotavirus causes severe vomiting and diarrhea and largely affects children. Over 200,000 children are killed by the virus each year. The rotavirus vaccine is made of weakened strains of the rotavirus, […]

August 9, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 17 Jul 2018

Gene Therapy Could Prevent Deadly Brain Disease

An international research team used gene therapy to prevent Gaucher disease, a potentially deadly neurodegenerative condition, in mice. The approach could eventually be used to treat human diseases in the womb. A research team from the UK and Singapore showed that a neurodegenerative condition called Gaucher disease, which can be fatal, can be prevented in […]

July 17, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 9 Jul 2018

Swedish Alzheimer’s Treatment Slows the Disease in Phase II Trial

BioArctic, based in Stockholm, has clinical results showing its antibody treatment that targets amyloid plaques, a hallmark of Alzheimer’s disease, can slow the disease’s progression. The trial tested the antibody in 856 patients with early-stage Alzheimer’s disease with plaques of amyloid-beta protein in their brains, which is considered a common hallmark of the disease. Results taken at […]

July 9, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 27 Jun 2018

International Fund Raises €300M for Dementia Research

The Dementia Discovery Fund has raised $350M (€300M) to support industrial and academic scientists doing early-stage research to develop new dementia medicines. Launched in 2015, the Dementia Discovery Fund (DDF) is dedicated to investing in early-stage ventures that develop disease-modifying therapeutics for all types of dementia, including Alzheimer’s and Parkinson’s. Yesterday, the DDF completed a […]

June 27, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Jun 2018

Our Eyes Could Open A Window to Diagnosing Alzheimer’s and Parkinson’s Disease

Spanish researchers have developed a way to diagnose neurodegenerative diseases by analyzing eye movements. The Madrid-based research team and its spin-off company Aura Innovative Robotics have developed a diagnostic test for neurodegenerative disease that tracks a patient’s eye movements and analyzes the data using machine learning. The diagnostic test, called OSCANN Desk, is currently being […]

June 14, 2018 - 2 minutesmins - By Alexander Burik

In Depth 29 May 2018

Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done?

With no drugs that can stop the progression of the disease and hundreds of clinical trials failing, new fields of research bring hope to people with Alzheimer’s. As the Western population ages, Alzheimer’s disease is becoming one of the biggest diseases of the 21st century. But despite the efforts of science, the FDA and EMA […]

May 29, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Neurodegenerative disease

As Big Pharma Abandons Neuroscience, Can Biotech Provide Answers?

German Biotech Will Target Parkinsonian Disorders with €12M Series A

Top 10 Biotechs in Lausanne

Swedish Biotech’s Stock Severely Hit by Failure of Biogen’s Alzheimer’s Drug

Update: The FDA Green-lights Clinical Trials for Huntington’s Disease Gene Therapy

This Company is Strengthening Muscles in Neuromuscular Disorders

Modulating the Microbiome Could Boost Vaccine Performance

Gene Therapy Could Prevent Deadly Brain Disease

Swedish Alzheimer’s Treatment Slows the Disease in Phase II Trial

International Fund Raises €300M for Dementia Research

Our Eyes Could Open A Window to Diagnosing Alzheimer’s and Parkinson’s Disease

Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done?

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!